Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Avigan, David
Item TypeName
Academic Article Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.
Academic Article Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome.
Academic Article Dendritic cell fusion vaccines for cancer immunotherapy.
Academic Article Can leukemia-derived dendritic cells generate antileukemia immunity?
Academic Article MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells.
Academic Article Dendritic cell-tumor fusion vaccines for renal cell carcinoma.
Academic Article Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myeloma.
Academic Article The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses.
Academic Article Vaccine therapy and adoptive immunotherapy in hematologic malignancies.
Academic Article Cellular immunotherapy for multiple myeloma.
Academic Article Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses.
Academic Article Update on cancer vaccines.
Academic Article The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.
Academic Article Lenalidomide enhances anti-myeloma cellular immunity.
Academic Article Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation.
Academic Article Dendritic/tumor fusion cells as cancer vaccines.
Academic Article PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.
Academic Article Induction of antitumor immunity ex vivo using dendritic cells transduced with fowl pox vector expressing MUC1, CEA, and a triad of costimulatory molecules (rF-PANVAC).
Academic Article Dendritic cell defects in patients with cancer: mechanisms and significance.
Academic Article Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma.
Academic Article Dendritic cell/tumour fusions vaccine.
Academic Article Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28.
Academic Article Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.
Academic Article Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.
Academic Article A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studies.
Academic Article Fusions of breast cancer and dendritic cells as a novel cancer vaccine.
Academic Article Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors: a case series with a review of the literature.
Academic Article Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
Academic Article A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
Academic Article Dendritic cells: development, function and potential use for cancer immunotherapy.
Academic Article Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells.
Academic Article Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer.
Academic Article Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
Academic Article Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma.
Academic Article Advances in the development of a therapeutic cancer vaccine.
Academic Article Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.
Academic Article Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblasts.
Academic Article Acute cor pulmonale due to tumor emboli. Diagnosis by pulmonary artery catheterization.
Academic Article Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity.
Academic Article Innovations and challenges in renal cancer: consensus statement from the first international conference.
Academic Article A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells.
Academic Article Cancer vaccines in hematologic malignancies: advances, challenges and therapeutic potential.
Concept Breast Neoplasms
Concept Neoplasms, Hormone-Dependent
Concept Immunotherapy, Active
Concept Neoplasms, Experimental
Concept Immunotherapy, Adoptive
Concept Cancer Vaccines
Concept Ovarian Neoplasms
Concept Kidney Neoplasms
Concept Immunotherapy
Concept Brain Neoplasms
Concept Lung Neoplasms
Concept Skin Neoplasms
Concept National Cancer Institute (U.S.)
Concept Neoplasms
Concept Prostatic Neoplasms
Concept Hematologic Neoplasms
Academic Article The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.
Academic Article Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.
Academic Article MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.
Academic Article Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies.
Academic Article Immunotherapy for multiple myeloma.
Academic Article Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation.
Academic Article Dendritic cell cancer vaccines: from the bench to the bedside.
Academic Article Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation.
Academic Article Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies.
Academic Article Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma.
Academic Article Role of Immune Therapies for Myeloma.
Academic Article Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies.
Academic Article Immune therapy in multiple myeloma.
Academic Article Ipilimumab for Patients with Relapse after Allogeneic Transplantation.
Academic Article Myeloid-derived suppressor cells as effectors of immune suppression in cancer.
Grant RHIL-12 FOLLOWING HIGH DOSE CHEMOTHERAPY
Academic Article MUC1 in hematological malignancies.
Academic Article Challenges in vaccine therapy in hematological malignancies and strategies to overcome them.
Academic Article Persistence of dysphagia and odynophagia after mediastinal radiation and chemotherapy in patients with lung cancer or lymphoma.
Academic Article Dynamic analysis of immune and cancer cell interactions at single cell level in microfluidic droplets.
Academic Article Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.
Academic Article The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
Academic Article Leukemia derived dendritic cells (LDCs) may be ineffective as a cancer vaccine for acute myeloid leukemia (AML).
Academic Article Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.
Academic Article DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma.
Academic Article Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutation.
Grant Directed Purinergic Signaling as Immunotherapy in Leukemia
Academic Article Anti-cancer vaccine therapy for hematologic malignancies: An evolving era.
Academic Article Vaccine therapy in hematologic malignancies.
Academic Article Prevention and treatment of relapse after stem cell transplantation with immunotherapy.
Academic Article Cellular immunotherapy as a therapeutic approach in multiple myeloma.
Academic Article First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Academic Article Cellular Immunotherapy for Multiple Myeloma.
Academic Article Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
Academic Article Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy.
Academic Article Advances in the development of vaccines and other immunotherapies for multiple myeloma.
Academic Article The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma.
Search Criteria
  • Cancer
  • immunotherapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.